Endothelin-1 receptors play a minor role in the protection against acute Trypanosoma cruzi infection in mice

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 3, 2007, Pages 391-399

  Roffe E ^a   Souza, A L S ^a   Machado, P P ^a   Barcelos, L S ^a   Romanha, A J ^b   Mariano, F S ^c   Silva, J S ^c   Machado, C R ^a   Tanowitz, H B ^d   Teixeira, M M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokines; Endothelin; Myocarditis; Trypanosoma cruzi

Indexed keywords

BOSENTAN; CYTOKINE; ENDOTHELIN 1; ENDOTHELIN 1 RECEPTOR; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CHAGAS DISEASE; CONTROLLED STUDY; HEART PROTECTION; IN VITRO STUDY; INCUBATION TIME; INFECTION CONTROL; LETHALITY; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PARASITEMIA; PATHOGENESIS; PERITONEUM MACROPHAGE; PROTEIN FUNCTION; TRYPANOSOMA CRUZI; VASOCONSTRICTION;

ANIMALIA; MURINAE; MUS; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 33947166708     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000300015     Document Type: Article

References (31)

1. Rocha MC, Ribeiro AL, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Front Biosci 2003; 8: e44-e54.
2. Hickey KA, Rubanyi G, Paul RJ, Highsmith RF. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 1985; 248: C550-C556.
3. Gillespie MN, Owasoyo JO, McMurtry IF, O'Brien RF. Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J Pharmacol Exp Ther 1986; 236: 339-343.
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
5. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000; 102: 2434-2440.
6. Salomone CA, Caeiro TF, Madoery RJ, Amuchastegui M, Omelinauk M, Juri D, et al. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am J Cardiol 2001; 87: 1217-1220.
7. Wittner M, Christ GJ, Huang H, Weiss LM, Hatcher VB, Morris SA, et al. Trypanosoma cnizi induces endothelin release from endothelial cells. J Infect Dis 1995; 171: 493-497.
8. Huang H, Petkova SB, Pestell RG, Bouzahzah B, Chan J, Magazine H, et al. Trypanosoma cruzi infection (Chagas' disease) of mice causes activation of the mitogen-activated protein kinase cascade and expression of endothelin-1 in the myocardium. J Cardiovasc Pharmacol 2000; 36: S148-S150.
9. Petkova SB, Tanowitz HB, Magazine HI, Factor SM, Chan J, Pestell RG, et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc Pathol 2000; 9: 257-265.
10. Jelicks LA, Chandra M, Shirani J, Shtutin V, Tang B, Christ GJ, et al. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int J Parasitol 2002; 32: 1497-1506.
11. Morris SA, Weiss LM, Factor S, Bilezikian JP, Tanowitz H, Wittner M. Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. J Am Coll Cardiol 1989; 14: 782-789.
12. Tanowitz HB, Morris SA, Weiss LM, Bilezikian JP, Factor SM, Wittner M. Effect of verapamil on the development of chronic experimental Chagas' disease. Am J Trop Med Hyg 1989; 41: 643-649.
13. Chandra M, Shirani J, Shtutin V, Weiss LM, Factor SM, Petkova SB, et al. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil strain): an echocardiographic study. Int J Parasitol 2002; 32: 207-215.
14. Camargos ER, Machado CR, Teixeira AL Jr, Rocha LL, Ferreira AJ, Almeida AP, et al. Role of endothelin during experimental Trypanosoma cruzi infection in rats. Clin Sci 2002; 103 (Suppl 48): 64S-67S.
15. Camargos ER, Rocha LL, Rachid MA, Almeida AP, Ferreira AJ, Teixeira AL Jr, et al. Protective role of ETA endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats. Microbes Infect 2004; 6: 650-656.
16. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 1962; 4: 389-396.
17. Rachid MA, Camargos ER, Barcellos L, Marques CA, Chiari E, Huang H, et al. Blockade of endothelin ET(A)/ET(B) receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats. Microbes Infect 2006; 8: 2113-2119.
18. Opocensky M, Dvorak P, Maly J, Kramer HJ, Backer A, Kopkan L, et al. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats. Physiol Res 2004; 53: 581-593.
19. Souza DG, Cara DC, Cassali GD, Coutinho SF, Silveira MR, Andrade SP, et al. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br J Pharmacol 2000; 131: 1800-1808.
20. Aliberti JC, Machado FS, Souto JT, Campanelli AP, Teixeira MM, Gazzinelli RT, et al. Beta-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in mudne inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 1999; 67: 4819-4826.
21. Aliberti JC, Machado FS, Gazzinelli RT, Teixeira MM, Silva JS. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun 1999; 67: 2810-2814.
22. Petkova SB, Huang H, Factor SM, Pestell RG, Bouzahzah B, Jelicks LA, et al. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2001; 31: 499-511.
23. Tanowitz HB, Huang H, Jelicks LA, Chandra M, Loredo ML, Weiss LM, et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect Immun 2005; 73: 2496-2503.
24. Masaki T, Yanagisawa M. Cardiovascular effects of the endothelins. Cardiovasc Drug Rev 1990; 8: 373-385.
25. Parissis JT, Venetsanou KF, Kalantzi MV, Mentzikof DD, Karas SM. Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. Am J Cardiol 2000; 85: 777-779, A9.
26. Sampaio AL, Rae GA, Henriques MG. Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-incluced inflammation. J Leukoc Biol 2004; 76: 210-216.
27. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, et al. Dual effects of endothelin-1 (1-31): induction of mesangial call migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 2004; 27: 433-440.
28. Halim A, Kanayama N, el Maradny E, Maehara K, Terao T. Activated neutrophil by endothelin-1 caused tissue damage in human umbilical cord. Thromb Res 1995; 77: 321-327.
29. Zidovetzki R, Chen P, Chen M, Hofman FM. Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways. Blood 1999; 94: 1291-1299.
30. Coulombe M, Battistini B, Stankova J, Pouliot P, Bissonnette EY. Endothelins regulate mediator production of rat tissue-cultured mucosal mast cells. Up-regulation of Th1 and inhibition of Th2 cytokines. J Leukoc Biol 2002; 71: 829-836.
31. - production in human alveolar macrophages. Am J Physiol 1991; 261: L478-L484.